Evidence map›Paper›PMID 33792829›Full record

ArticleFamilial cancer2021

Correction to: Letter to the Editor-Recent advances in Lynch syndrome.

Pål Møller, Julian Sampson, Mev Dominguez-Valentin, John Burn, Lone Sunde, Gabriela Möslein, Jukka-Pekka Mecklin, Toni Seppälä

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Familial cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Pål MøllerDepartment of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. moller.pal@gmail.com.ORCID http://orcid.org/0000-0001-8211-8237
Julian SampsonDivision of Cancer and Genetics, Institute of Medical Genetics, Cardiff University School of Medicine, Cardiff, UK.
Mev Dominguez-ValentinDepartment of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
John BurnFaculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
Lone SundeDepartment of Clinical Genetics, Aalborg University Hospital, Aalborg, Denmark.
Gabriela MösleinCenter for Hereditary Tumors, University Witten/ Herdecke, Ev. Bethesda Khs zu Duisburg, Witten, Germany.
Jukka-Pekka MecklinDepartment of Surgery, Central Finland Health Care District, and Sport and Health Sciences, University of Jyväskylä, Jyväskylä, Finland.
Toni SeppäläDepartment of Surgery, Helsinki University Hospital, Helsinki, Finland.

Funding

Cancer Research UK 15934Medical Research Council G0100496
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33792829

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.